Press Release
Plasma Fractionation Market Set to Surpass USD 52 Billion by 2032
Pune, December 8, 2025 – Global Data Route Analytics has released its latest in-depth study titled “Global Plasma Fractionation Market Outlook 2020–2035: Size, Share, Growth Trends & Industry Forecast.” The report reveals that the global plasma fractionation market is projected to expand from approximately USD 30.8 billion in 2024 to USD 52.4 billion by 2032, advancing at a compound annual growth rate (CAGR) of 6.6%. This growth is being driven by the increasing adoption of plasma-derived therapies for treating chronic and rare diseases.
For a free sample of the report, please contact us here.
https://globaldatarouteanalytics.com/report/247/global-plasma-fractionation-market/download
Plasma fractionation plays a vital role in producing essential life-saving therapies such as immunoglobulins, coagulation factors, and albumin, which are crucial in immunology, hematology, neurology, and critical care. Rising incidences of immune deficiencies, hemophilia, and liver disorders are further boosting demand for these products across global healthcare systems.
In addition, recent advancements in fractionation technology, improvements in plasma collection networks, and expansion of manufacturing capacities are significantly enhancing both efficiency and quality. Collaborations between major biopharma companies and healthcare providers are also expanding treatment access and strengthening supply chain resilience.
For any inquiry related to this report, please click here.
https://globaldatarouteanalytics.com/report/247/global-plasma-fractionation-market/inquiry
The report segments the global plasma fractionation market as follows:
By Product
• Immunoglobulins
• Coagulation Factors
• Albumin
• Protease Inhibitors
• Other Plasma-Derived Products
By Application
• Neurology
• Immunology
• Hematology
• Critical Care
• Pulmonology
• Other Applications
By End User
• Hospitals and Clinics
• Research Laboratories
• Academic Institutes
• Other End Users
By Region
• North America (United States, Canada)
• Europe (Germany, UK, France, Italy, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of Asia-Pacific)
• Latin America (Brazil, Mexico, Rest of Latin America)
• Middle East and Africa (South Africa, Saudi Arabia, UAE, Rest of MEA)
Key players profiled include CSL Behring, Grifols, Octapharma, Kedrion, Takeda Pharmaceutical Company Limited, Bio Products Laboratory, Sanquin, China Biologic Products Holdings Inc., LFB Group, and Biotest AG.
For discounts related to this report, explore here.
https://globaldatarouteanalytics.com/report/247/global-plasma-fractionation-market/discount
About the Company
Global Data Route Analytics is a market research and consulting firm that provides businesses with data analysis, market forecasts, and tailored reports across various industries. The company uses advanced data analysis techniques, proprietary data, and an expert team to help clients understand market trends, make informed decisions, and develop strategies. They focus on delivering customized solutions, competitive intelligence, and growth strategies to help businesses succeed in their respective markets.
Media Contact:
Srushti Tungar
Global Data Route Analytics
